Literature DB >> 2543386

Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells.

Z Ziaie1, N A Kefalides.   

Abstract

In previous studies we have shown that herpes simplex virus type 1 (HSV-1) infection suppresses host-cell protein synthesis in human endothelial cells (EC). It has been demonstrated that lithium salts prevent viral replication in HSV-1 infected cells. In the present study, we have measured host-cell protein synthesis in HSV-1 infected EC in the presence or absence of 20 and 30 mM LiCl. Although LiCl restored synthesis of almost all host-cell proteins, [35S]methionine incorporation was most pronounced in thrombospondin and plasminogen activator inhibitor 1 and least in fibronectin and type IV collagen. LiCl was more effective at the higher concentration (30 mM) and when the compound was added to the EC culture at the time of infection rather than after adsorption of HSV-1. Synthesis of virus proteins continued in LiCl-treated EC but at a reduced rate. The data suggest that LiCl not only interferes with virus replication, but may also, to some extent, interfere with the virion-associated inhibition of host protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543386     DOI: 10.1016/s0006-291x(89)80112-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model.

Authors:  Nina Tsao; Chih-Feng Kuo; Ching-Chen Chiu; Wei-Chen Lin; Wan-Hui Huang; Li-Yang Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

2.  Action mechanisms of lithium chloride on cell infection by transmissible gastroenteritis coronavirus.

Authors:  Xiaofeng Ren; Fandan Meng; Jiechao Yin; Guangxing Li; Xunliang Li; Chao Wang; Georg Herrler
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

Review 3.  HSV-1 and Alzheimer's disease: more than a hypothesis.

Authors:  Roberto Piacentini; Giovanna De Chiara; Domenica D Li Puma; Cristian Ripoli; Maria E Marcocci; Enrico Garaci; Anna T Palamara; Claudio Grassi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

4.  In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection.

Authors:  Hassan Z A Ishag; Yu-Zi Wu; Mao-Jun Liu; Qi-Yan Xiong; Zhi-Xin Feng; Ruo-Song Yang; Guo-Qing Shao
Journal:  Res Vet Sci       Date:  2016-04-04       Impact factor: 2.534

Review 5.  Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Authors:  Andrea Murru; Mirko Manchia; Tomas Hajek; René E Nielsen; Janusz K Rybakowski; Gabriele Sani; Thomas G Schulze; Leonardo Tondo; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2020-05-20

6.  Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus.

Authors:  Xiuwen Sui; Jiechao Yin; Xiaofeng Ren
Journal:  Antiviral Res       Date:  2009-10-30       Impact factor: 5.970

7.  Antiviral Effect of Lithium Chloride on Replication of Marek's Disease Virus in Chicken Embryonic Fibroblasts.

Authors:  Huifeng He; Dandan Qiao; Lu Zhang; Yongxiu Yao; Hongxia Shao; Aijian Qin; Kun Qian
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

8.  Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients.

Authors:  Carlos Spuch; Marta López-García; Tania Rivera-Baltanás; J J Cabrera-Alvargonzález; Sudhir Gadh; Daniela Rodrigues-Amorim; Tania Álvarez-Estévez; Almudena Mora; Marta Iglesias-Martínez-Almeida; Luis Freiría-Martínez; Maite Pérez-Rodríguez; Alexandre Pérez-González; Ana López-Domínguez; María Rebeca Longueira-Suarez; Adrián Sousa-Domínguez; Alejandro Araújo-Ameijeiras; David Mosquera-Rodríguez; Manuel Crespo; Dolores Vila-Fernández; Benito Regueiro; Jose Manuel Olivares
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

9.  Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.

Authors:  Yinxia Zhao; Kepeng Yan; Yanqi Wang; Jiamin Cai; Lin Wei; Shuijun Li; Wei Xu; Min Li
Journal:  Microb Pathog       Date:  2020-03-20       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.